These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38319449)

  • 41. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
    Khan N; Afaq F; Khusro FH; Mustafa Adhami V; Suh Y; Mukhtar H
    Int J Cancer; 2012 Apr; 130(7):1695-705. PubMed ID: 21618507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scutellarin improves the radiosensitivity of non-small cell lung cancer cells to iodine-125 seeds via downregulating the AKT/mTOR pathway.
    He GH; Xing DJ; Jin D; Lu Y; Guo L; Li YL; Li D
    Thorac Cancer; 2021 Sep; 12(17):2352-2359. PubMed ID: 34255431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.
    Xiao P; Sun LL; Wang J; Han RL; Ma Q; Zhong DS
    Acta Pharmacol Sin; 2015 Sep; 36(9):1107-12. PubMed ID: 26027660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
    Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y
    J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AMPK facilitates intestinal long-chain fatty acid uptake by manipulating CD36 expression and translocation.
    Wu W; Wang S; Liu Q; Shan T; Wang X; Feng J; Wang Y
    FASEB J; 2020 Apr; 34(4):4852-4869. PubMed ID: 32048347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
    Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
    Zhang C; Jin Y
    Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression.
    Zingg JM; Hasan ST; Nakagawa K; Canepa E; Ricciarelli R; Villacorta L; Azzi A; Meydani M
    Biofactors; 2017 Jan; 43(1):42-53. PubMed ID: 27355903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
    Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
    Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet.
    Lynes M; Narisawa S; Millán JL; Widmaier EP
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1738-47. PubMed ID: 21900644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells.
    Chiu LY; Hu ME; Yang TY; Hsin IL; Ko JL; Tsai KJ; Sheu GT
    PLoS One; 2015; 10(5):e0125774. PubMed ID: 25946033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
    Barroso E; Rodríguez-Rodríguez R; Zarei M; Pizarro-Degado J; Planavila A; Palomer X; Villarroya F; Vázquez-Carrera M
    Cell Commun Signal; 2020 Sep; 18(1):147. PubMed ID: 32912335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway.
    Guo Z; Ye H; Zheng X; Yin W; He J
    J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muyin extract inhibits non-small-cell lung cancer growth by inducing autophagy and apoptosis in vitro and in vivo.
    Kan Y; Song M; Cui X; Yang Q; Zang Y; Li Q; Li Y; Cai W; Chen Y; Weng X; Wang Y; Zhu X
    Phytomedicine; 2022 Feb; 96():153834. PubMed ID: 34952294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.